Atul Gawande and Hendrik Hertzberg nominated for National Magazine Awards

The New Yorker contributors are recognized for medical reporting and commentary.

Among New Yorker contributors nominated for National Magazine Awards are associate professor of surgery Atul Gawande, for one of his articles on medicine, and Hendrik Hertzberg ’65, for three of his Talk of the Town commentaries. Winners will be announced on May 9. The American Society of Magazine Editors' announcement provides links to each author's nominated works—in the Public Interest category for Gawande and in Columns & Commentary for Hertzberg's essays.

Elizabeth Gudrais's profile of  Gawande, "The Unlikely Writer," appeared in the September-October 2009 Harvard Magazine. Craig Lambert's profile of "Hertzberg of the New Yorker" appeared in the January-February 2003 issue. 

 

Related topics

You might also like

A History of Harvard Magazine

Harvard’s independent alumni magazine—at 127 years old 

A (Truly) Naked Take on Second-Wave Feminism

Playwright Bess Wohl’s Liberation opens on Broadway.

Most popular

Five Questions with Michèle Duguay

Harvard scholar of music theory on how streaming services have changed the experience of music.

Harvard art historian Jennifer Roberts teaches the value of immersive attention

Teaching students the value of deceleration and immersive attention

Explore More From Current Issue

A vibrant composition of flowers, a bird, and butterflies with a distant manor under a moody sky.

Rachel Ruysch’s Lush (Still) Life

Now on display at the Museum of Fine Arts, a Dutch painter’s art proved a treasure trove for scientists.

A lively concert in a modern auditorium with an audience seated on multiple levels.

Concerts and Carols at the Isabella Stewart Gardner Museum

Tuning into one of Boston's best chamber music halls 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.